Univariate and multivariate survival analysis in GC NAC cohort
Characteristics | Number | Univariate | Multivariate | ||||
Class | Total | Event (OS) | HR (95% CI) | P value | HR (95% CI) | P value | |
Age | 1.006 (0.991 to 1.020) | 0.450 | |||||
Histology | Adenocarcinoma | 283 | 161 | 1 | 1 | ||
Signet-ring cell carcinoma (SRCC) | 19 | 15 | 1.772 (1.043 to 3.009) | 0.034 | 1.993 (0.968 to 4.105) | 0.061 | |
Differentiation | |||||||
Poor | 135 | 91 | 1 | 1 | |||
Well/moderate | 144 | 74 | 0.632 (0.465 to 0.859) | 0.003 | 0.636 (0.439 to 0.922) | 0.017 | |
Tumor diameter | |||||||
<5 cm | 151 | 72 | 1 | ||||
≥5 cm | 137 | 97 | 1.870 (1.378 to 2.538) | <0.001 | |||
Vascular invasion | |||||||
Negative | 174 | 80 | 1 | ||||
Positive | 123 | 93 | 2.605 (1.926 to 3.523) | <0.001 | |||
NAC response | |||||||
Responders | 28 | 10 | 1 | ||||
Non-responders | 276 | 167 | 2.116 (1.118 to 4.007) | 0.021 | |||
pTNM | |||||||
I | 23 | 1 | 1 | 1 | |||
II | 95 | 30 | 7.711 (1.051 to 56.543) | 0.045 | 3.627 (0.488 to 26.968) | 0.208 | |
III | 127 | 99 | 30.607 (4.263 to 219.727) | 0.001 | 12.691 (1.760 to 91.496) | 0.012 | |
IV | 43 | 39 | 47.637 (6.530 to 347.492) | <0.001 | 17.340 (2.346 to 128.150) | 0.005 | |
CD3 | 0.982 (0.965 to 0.999) | 0.043 | |||||
CD8 | 0.972 (0.953 to 0.991) | 0.004 | 0.967 (0.946 to 0.989) | 0.004 | |||
CD4 | 0.984 (0.957 to 1.012) | 0.255 | |||||
FOXP3 | 1.004 (0.906 to 1.113) | 0.944 | |||||
Granzyme B | 0.943 (0.860 to 1.035) | 0.220 | |||||
CD20 | 1.004 (0.982 to 1.027) | 0.725 | |||||
CD68 | 0.997 (0.963 to 1.032) | 0.873 | |||||
CD57 | 1.009 (0.987 to 1.032) | 0.439 |
GC, gastric cancer; NAC, neoadjuvant chemotherapy.